• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
COPD
COPD

... do not relieve symptoms within 24 hours. ...
Untitled (English)
Untitled (English)

... recurring symptoms, reversible airflow obstruction and bronchospasm; common symptoms include wheezing, coughing, chest tightness and shortness of breath. (1, 2).Asthma is thought to be caused by a combination of genetic and environmental factors; its diagnosis is usually based on pattern of symptoms ...


... Hospital, University of Ottawa, Ottawa, Canada determine whether methotrexate is an effective steroidObjective: To for with severe asthma. ...
Managing work-aggravated asthma
Managing work-aggravated asthma

... Some newly established causes  Diesel – irritant. Also acts as an adjuvant for sensitisation to aeroallergens. Cases of OA wit latency have been described in bus garage workers where diesel exhaust was the most likely cause ...
Asthma and Reactive Airway Disease
Asthma and Reactive Airway Disease

... – Reactive airway disease is a general term that doesn't indicate a specific diagnosis. It may be used to describe a history of coughing, wheezing or shortness of breath of unknown cause. These signs and symptoms may or may not be caused by asthma. Reactive airway disease isn't really a specific dia ...
Final, OSAS, ASTHMA - The Egyptian Society of Chest Diseases
Final, OSAS, ASTHMA - The Egyptian Society of Chest Diseases

... Possible: Airways cooling Supine posture Allergic Factors Gastroesophageal reflux Snoring or Sleep Apnea Sutherland, (2005) ...
ABNORMAL NEURAL CONTROL OF AIRWAYS
ABNORMAL NEURAL CONTROL OF AIRWAYS

... more sensitive than skin test, results independent of therapy, skin lesions, dermographism, no risk of excessive (allergic/anaphylactic) reaction  normal values does not exclude allergy A.Bręborowicz-2006 ...
Is spirometry essential in diagnosing asthma? No
Is spirometry essential in diagnosing asthma? No

... to record the best of three readings twice a day, when symptoms occur, and if appropriate, in combination with a trial of treatment. This should be followed by a review a few weeks later. In conclusion, primary care health professionals are likely to be consulted by many people with undiagnosed asth ...
Treatment and Management of Elderly Bronchial Asthma
Treatment and Management of Elderly Bronchial Asthma

... of elderly patients, the airway space distal from the respiratory bronchiole to the alveolar duct and alveolus is dilated, causing age-related changes, such as an increase in residual volume and decrease in forced expiratory volume per 1 sec (FEV1) by 25 to 30 ml/year. In asthmatic patients, the dec ...
Asthma COPD
Asthma COPD

... Describes the proportion of a person’s vital capacity (maximum air expelled after maximum inhalation) that can be expired in the first second. ...
sthma_COPD.pp
sthma_COPD.pp

... Late phase response: 5 – 6 hours ...
Asthma Health Management Program
Asthma Health Management Program

... for six visits during the six-month program, although the physician or asthma educator may extend the duration as necessary. ...
CHILDHOOD ASTHMA
CHILDHOOD ASTHMA

... minimal absences from school minimal need for use of beta agonist elimination of necessity for ED visit/warded restoration to and maintenance of normal PEF and minimal adverse effects from medications ...
Brenda takes care of Tabitha, her seven year old tabby cat. Tabitha
Brenda takes care of Tabitha, her seven year old tabby cat. Tabitha

... Treatment for feline asthma involves muting the hyper active immune response using corticosteroids such as prednisone. In the cases that involve secondary bacterial infections, we also treat with appropriate antibiotics. Some cats will tolerate inhaled therapy for asthma, which can be quite effectiv ...
Severe Asthma Associated With Myasthenia Gravis and Upper
Severe Asthma Associated With Myasthenia Gravis and Upper

... In this case, near-fatal asthma was complicated by tracheal stenosis and MG 3 years later. Abnormal antibody production is recognized as the basis for many diseases, among them asthma and autoimmune diseases. It is not unusual to find 2 or more of these diseases in the same patient. However, a searc ...
Just - About Asthma infographic
Just - About Asthma infographic

... how fast a person can blow air out of their lungs in one breath ...
ALLSA 2005 Congress – Advances in Asthma and Food Allergy
ALLSA 2005 Congress – Advances in Asthma and Food Allergy

... additives. Additives may be present in dyes, antioxidants, flavouring (MSG), preservatives, antimicrobials and stabilisers. The task of assessing reactions is complicated by the vast number of additives used – approved food additives in the USA total 2 977! Prof. Bahna listed the possible reactions ...
asthma - Yengage
asthma - Yengage

...  This may be a test of compliance with therapy  It may also be useful in demonstrating insufficient anti-inflammatory therapy ...
New Strategies in the Management of Asthma
New Strategies in the Management of Asthma

... potency); no side effects (low systemic effects)  fluticasone, budesonide ****  beclomethasone *  (triamcinolone, flunisolide) ...
New Strategies in the Management of Asthma
New Strategies in the Management of Asthma

... potency); no side effects (low systemic effects)  fluticasone, budesonide ****  beclomethasone *  (triamcinolone, flunisolide) ...
jerome
jerome

... Home characteristics ...
A1988P408800001
A1988P408800001

... By 1960 asthma was the major respiratory probthey fall into fits of difficult breathing. lem in paediatrics, as the frequency of tuberculosis and suppurating lung disease was greatly reduced If Willis could be present at a world symposium on due to effective medical treatment. A major prob- asthma i ...
SLIT - BSACI
SLIT - BSACI

... Seasonal allergic rhinitis is an IgE-mediated hypersensitivity inflammatory disorder characterised by watery nasal discharge, itchy nose, sneezing, nasal congestion and associated eye symptoms1-3. Seasonal allergic rhinitis is a significant cause of morbidity, negatively impacting on sleep, home, wo ...
WAC Small Airways 12-7
WAC Small Airways 12-7

... Mean (SE) post-bronchodilator FEF 25-75% (%predicted) ...
Breath for Life Program - Credit Valley Family Health Team
Breath for Life Program - Credit Valley Family Health Team

... Asthma is a long term disease that affects the air passages in the lungs. Air passages are tiny breathing tubes that carry air in and out of the lungs. People who suffer from asthma have very sensitive air passages, especially when they are exposed to things they are allergic to. ...
< 1 2 3 >

Omalizumab

Omalizumab (trade name Xolair, Roche/Genentech and Novartis) is a humanized antibody originally designed to reduce sensitivity to inhaled or ingested allergens, especially in the control of moderate to severe allergic asthma, which does not respond to high doses of corticosteroids. It has been approved for treating adult and adolescent patients 12 years and older with severe or moderate to severe allergic asthma in more than 90 countries, since its first of such approval in 2002 in Australia. Omalizumab was approved in March 2014 in the European Union and the U.S.A. and in about 10 other countries for treating patients 12 years and above with chronic spontaneous urticaria (CSU) (also referred to as chronic idiopathic urticaria or CIU), which cannot be treated with H1-antihistamines. CSU is not an allergic disease. Presently, the drug is being actively studied in clinical trials for various allergic diseases and some non-allergic diseases, especially skin diseases.Omalizumab is a recombinant DNA-derived humanized IgG1k monoclonal antibody that specifically binds to free human immunoglobulin E (IgE) in the blood and interstitial fluid and to membrane-bound form of IgE (mIgE) on the surface of mIgE-expressing B lymphocytes. Unlike an ordinary anti-IgE antibody, it does not bind to IgE that is already bound by the high affinity IgE receptor (FcεRI) on the surface of mast cells, basophils, and antigen-presenting dendritic cells.IgE is commonly involved in type I hypersensitivity, which manifests the most prevalent allergic diseases. It has been estimated that as high as 20 to 40% of the populations who live a western lifestyle in economically advanced countries are affected by allergy and seek medical help. In the U.S., 8% of adults and 10% of children have asthma. Allergy occurs more frequently in individuals with higher serum IgE levels, though some allergic individuals have very low serum IgE, and some people with very high IgE have no allergic problems.
  • studyres.com © 2026
  • DMCA
  • Privacy
  • Terms
  • Report